Literature DB >> 27358810

Food assistance to tuberculosis patients: lessons from Afghanistan.

D Pedrazzoli1, R M Houben1, N Grede2, S de Pee3, D Boccia4.   

Abstract

Poverty, food insecurity and poor nutrition in the population are important contributors to the burden of tuberculosis (TB). For poor and food-insecure individuals, accessing and successfully completing anti-tuberculosis treatment over an extended period of time is challenging. Food and nutritional support as an incentive and enabler is employed by national TB control programmes (NTPs) worldwide as a means to encourage treatment initiation and adherence and to improve the nutritional status of patients with TB. It also offers a safety net for food-insecure households affected by TB to mitigate the financial consequences of the disease. This paper reports on the primary lessons from the review of the World Food Programme's (WFP's) Food Assistance Programme for TB patients in Afghanistan. It aims to inform the design, implementation and scale-up of TB programmes in settings where food insecurity and malnutrition are prevalent. It also documents qualitative findings that suggest that patients, their families and providers viewed food support as an important asset and an essential element of the national TB control strategy. While the impact on treatment success or case detection could not be quantified, it is likely that the WFP intervention had a positive impact on the patients and their households, therefore contributing to the success of the DOTS-based NTP.

Entities:  

Keywords:  TB; enablers; nutrition; transfers

Year:  2016        PMID: 27358810      PMCID: PMC4913679          DOI: 10.5588/pha.15.0076

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  23 in total

1.  Cured and starved: food for thought.

Authors:  Knut Lönnroth
Journal:  Public Health Action       Date:  2013-06-21

2.  Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes.

Authors:  João Paulo Cantalice Filho
Journal:  J Bras Pneumol       Date:  2009-10       Impact factor: 2.624

Review 3.  A consistent log-linear relationship between tuberculosis incidence and body mass index.

Authors:  Knut Lönnroth; Brian G Williams; Peter Cegielski; Christopher Dye
Journal:  Int J Epidemiol       Date:  2009-10-09       Impact factor: 7.196

Review 4.  The enabling effect of food assistance in improving adherence and/or treatment completion for antiretroviral therapy and tuberculosis treatment: a literature review.

Authors:  Saskia de Pee; Nils Grede; Divya Mehra; Martin W Bloem
Journal:  AIDS Behav       Date:  2014-10

5.  Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection.

Authors:  Knut Lönnroth; Tin Aung; Win Maung; Hans Kluge; Mukund Uplekar
Journal:  Health Policy Plan       Date:  2007-04-12       Impact factor: 3.344

6.  Socio-economic impact of tuberculosis on patients and family in India.

Authors:  R Rajeswari; R Balasubramanian; M Muniyandi; S Geetharamani; X Thresa; P Venkatesan
Journal:  Int J Tuberc Lung Dis       Date:  1999-10       Impact factor: 2.373

7.  Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death.

Authors:  R Zachariah; M P Spielmann; A D Harries; F M L Salaniponi
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 May-Jun       Impact factor: 2.184

Review 8.  The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals.

Authors:  J P Cegielski; D N McMurray
Journal:  Int J Tuberc Lung Dis       Date:  2004-03       Impact factor: 2.373

9.  Scaling up TB DOTS in a fragile state: post-conflict Afghanistan.

Authors:  H Ahmadzai; F Kakar; M Rashidi; P G Suarez; O Ameli; A F Hartman
Journal:  Int J Tuberc Lung Dis       Date:  2008-02       Impact factor: 2.373

10.  Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.

Authors:  Tom Wingfield; Delia Boccia; Marco Tovar; Arquímedes Gavino; Karine Zevallos; Rosario Montoya; Knut Lönnroth; Carlton A Evans
Journal:  PLoS Med       Date:  2014-07-15       Impact factor: 11.069

View more
  5 in total

1.  Rare septic arthritis of the wrist and carpus primary osteoarticular manifestation of Mycobacterium tuberculosis: A case report.

Authors:  Nathan R Angerett; Zhongming Chen; Joseph J Kromka; Anna E Muzio; Michael E Kahan; John V Ingari; Robert J Maurer
Journal:  SAGE Open Med Case Rep       Date:  2022-05-21

2.  Influence of patients' living conditions on tuberculosis treatment outcomes in a South African health sub-district.

Authors:  Tombo Bongongo; Hendry Van der Heever; Doudou K Nzaumvila; Christian N S Saidiya
Journal:  S Afr Fam Pract (2004)       Date:  2020-08-25

3.  Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.

Authors:  T Tupasi; A M C G Garfin; J M Mangan; R Orillaza-Chi; L C Naval; G I Balane; R Basilio; A Golubkov; E S Joson; W-J Lew; V Lofranco; M Mantala; S Pancho; J N Sarol; A Blumberg; D Burt; E V Kurbatova
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

4.  Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.

Authors:  William E Rudgard; Carlton A Evans; Sedona Sweeney; Tom Wingfield; Knut Lönnroth; Draurio Barreira; Delia Boccia
Journal:  PLoS Med       Date:  2017-11-07       Impact factor: 11.069

5.  Impact of community-based adherence support on treatment outcomes for tuberculosis, leprosy and HIV/AIDS-infected individuals in post-Ebola Liberia.

Authors:  Julia H Rogers; Lassana Jabateh; Jason Beste; Bradley H Wagenaar; Ryan McBain; Daniel Palazuelos; Eugene Wickett; Catherine Oswald; Harriet G Napier; Julia Toomey-Garbo
Journal:  Glob Health Action       Date:  2018       Impact factor: 2.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.